Dan Kutz's questions to Perimeter Acquisition Corp. I (PMTR) leadership • Q1 2025
Question
Asked for an overview of the economic sensitivity across the company's business lines, whether macroeconomic concerns are affecting the transition to fluorine-free suppressants, and if there are any adjustments to the full-year 2025 financial outlook.
Answer
Management confirmed that the retardant and suppressant businesses have very low economic sensitivity, while the specialty products business has a modest link to miles driven. The transition to fluorine-free products continues unabated by macro concerns so far. The full-year financial assumptions remain unchanged, with strong Q1 working capital performance viewed as a timing benefit.